Skip to main content
Equibles

SEI INVESTMENTS CO

Position in FATE — Fate Therapeutics Inc

CIK 350894 OAKS, PA
Back to FATE Full portfolio

Position in FATE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$191,645
+$25,350 QoQ
Shares Held
70,980
-48.8% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 156 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in FATE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SEI INVESTMENTS CO holds $1,273,690,748 across 210 Biotechnology names. FATE ranks #163 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 255,073 $236,649,076
2 INSM
INSMED Inc
 1,015,870 $108,312,059
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 129,981 $64,565,461
4 EXEL
Exelixis, Inc.
 1,166,715 $63,480,962
5 ASND
Ascendis Pharma A/S
 237,869 $63,444,419
6 INCY
Incyte Corp
 498,013 $56,454,752
7 HALO
Halozyme Therapeutics, Inc.
 551,116 $43,135,848
8 REGN
Regeneron Pharmaceuticals, Inc.
 60,441 $37,687,380

All Filings in FATE

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $191,645 70,980
2026-03-31 $166,295 138,580
2025-12-31 $66,289 67,643
2025-09-30 $85,328 67,721
2025-06-30 $75,846 67,721
2025-03-31 $53,595 67,843
2023-12-31 $67,566 18,066
2022-09-30 $1,459,876 65,144
2022-06-30 $1,310,936 52,903
2021-09-30 $350,996 5,922
2021-06-30 $588,609 6,782
2021-03-31 $1,569,269 19,033
2020-12-31 $1,673,383 18,403
2020-09-30 $825,180 20,645
2020-06-30 $553,180 16,123
2020-03-31 $537,615 24,206